Zu "168273-06-1" wurden 2 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Rimonabant
Artikelnummer: TGM-T1519L-100mg
Description: Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the...
| Schlagworte: | SR141716 |
| Anwendung: | Targets cannabinoid receptor 1 (CNR1) |
| CAS | 168273-06-1 |
| MW: | 463.79 D |
ab 42,00 €
Rimonabant
Artikelnummer: Cay9000484-10
Rimonabant is a cannabinoid 1 (CB1) receptor antagonist (Ki = 5.6 nM). It is selective for CB1 over CB2 receptors (Ki = >1,000 nM), as well as a panel of 37 other receptors and channels (IC50s = >1,000 nM). Rimonabant (10 µM) inhibits phytohemagglutinin-induced proliferation of isolated human peripheral blood...
| Schlagworte: | SR141716, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide |
| Anwendung: | CB1 receptor inverse agonist |
| CAS | 168273-06-1 |
| MW: | 463.8 D |
ab 63,00 €
